$IVDN
INNOVATIVE DESIGNS INC Stock $ivdn

$ivdn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000173112224001521 Filed on October 01, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$278.3K	$300.3K	$27.25K
YoY Change	123.25%	1002.13%	-27.76%
Cost Of Revenue		$151.6K	$13.35K
YoY Change		1035.28%	-37.35%
Gross Profit		$148.8K	$13.90K
YoY Change		970.29%	-15.3%
Gross Profit Margin		49.54%	51.01%
Selling, General & Admin	$142.2K	$121.0K	$121.9K
YoY Change	13.83%	-0.67%	-56.47%
% of Gross Profit		81.36%	876.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.324K	$1.165K	$770.00
YoY Change	72.17%	51.3%	102.63%
% of Gross Profit		0.78%	5.54%
Operating Expenses	$332.2K	$121.0K	$121.9K
YoY Change	64.93%	-0.67%	-56.47%
Operating Profit	-$53.92K	$27.73K	-$108.0K
YoY Change	-29.77%	-125.69%	-59.04%
Interest Expense		-$4.340K	-$4.630K
YoY Change		-6.26%	-62.23%
% of Operating Profit		-15.65%
Other Income/Expense, Net	-$5.161K	-$5.503K	$0.00
YoY Change	-28.22%
Pretax Income		$22.23K	-$112.6K
YoY Change		-119.74%	-59.18%
Income Tax
% Of Pretax Income
Net Earnings	-$59.08K	$22.23K	-$112.6K
YoY Change	-29.63%	-119.74%	-59.18%
Net Earnings / Revenue	-21.23%	7.4%	-413.17%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	37.92M shares	37.92M shares	35.18M shares
Diluted Shares Outstanding	37.84M shares	37.46M shares	35.91M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$241.7K	$65.01K
YoY Change		271.8%	-70.42%
Cash & Equivalents	$284.3K	$241.7K	$65.01K
Short-Term Investments
Other Short-Term Assets	$34.00K
YoY Change
Inventory	$471.1K	$523.4K	$630.0K
Prepaid Expenses
Receivables	$57.27K	$123.2K	$1.910K
Other Receivables		$16.54K	$0.00
Total Short-Term Assets	$846.7K	$904.9K	$696.9K
YoY Change	10.28%	29.84%	-14.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.38K	$21.15K	$25.02K
YoY Change	21.19%	-15.47%	272.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$652.9K	$660.1K
YoY Change		-1.09%	3.17%
Total Long-Term Assets	$682.3K	$674.1K	$685.2K
YoY Change	-9.91%	-1.62%	5.97%
TOTAL ASSETS
Total Short-Term Assets	$846.7K	$904.9K	$696.9K
Total Long-Term Assets	$682.3K	$674.1K	$685.2K
Total Assets	$1.529M	$1.579M	$1.382M
YoY Change	0.25%	14.25%	-5.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$79.69K	$60.65K	$210.8K
YoY Change	-71.07%	-71.23%	-16.49%
Accrued Expenses			$69.50K
YoY Change			-7.04%
Deferred Revenue
YoY Change
Short-Term Debt		$72.32K	$79.67K
YoY Change		-9.23%	-54.64%
Long-Term Debt Due			$19.95K
YoY Change			7.09%
Total Short-Term Liabilities	$246.1K	$231.8K	$379.9K
YoY Change	-42.14%	-38.99%	-27.14%
LONG-TERM LIABILITIES
Long-Term Debt		$42.36K	$54.80K
YoY Change		-22.7%	-60.92%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$37.24K	$42.36K	$54.80K
YoY Change	-24.82%	-22.7%	-60.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$246.1K	$231.8K	$379.9K
Total Long-Term Liabilities	$37.24K	$42.36K	$54.80K
Total Liabilities	$283.3K	$274.2K	$434.7K
YoY Change	-40.33%	-36.93%	-34.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.74M	-$10.64M	-$10.51M
YoY Change	1.38%	1.23%
Common Stock	$11.98M	$11.98M	$11.45M
YoY Change	2.93%	4.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.246M	$1.305M	$947.3K
YoY Change
Total Liabilities & Shareholders Equity	$1.529M	$1.579M	$1.382M
YoY Change	0.25%	14.25%	-5.17%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$59.08K	$22.23K	-$112.6K
YoY Change	-29.63%	-119.74%	-59.18%
Depreciation, Depletion And Amortization	$1.324K	$1.165K	$770.00
YoY Change	72.17%	51.3%	102.63%
Cash From Operating Activities		-$97.36K	-$42.92K
YoY Change		126.84%	-41.98%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$39.58K
YoY Change		-100.0%
Cash From Investing Activities		$0.00	-$39.58K
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		130.9K	-21.88K
YoY Change		-698.31%	-672.77%
NET CHANGE
Cash From Operating Activities		-97.36K	-42.92K
Cash From Investing Activities		0.000	-39.58K
Cash From Financing Activities		130.9K	-21.88K
Net Change In Cash		33.55K	-104.4K
YoY Change		-132.14%	48.77%
FREE CASH FLOW
Cash From Operating Activities		-$97.36K	-$42.92K
Capital Expenditures			$0.00
Free Cash Flow			-$42.92K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001190370
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-04-30
	dei	City Area Code CityAreaCode	412
	dei	Local Phone Number LocalPhoneNumber	799-0350
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37924003	shares
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241712	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	238677	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	123170	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31050	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	523443	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	549276	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	16541	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	8200	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	904866	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	827203	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21150	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23479	usd
CY2024Q2	us-gaap	Deposits On Flight Equipment DepositsOnFlightEquipment	652944	usd
CY2023Q4	us-gaap	Deposits On Flight Equipment DepositsOnFlightEquipment	652944	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	674094	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	676423	usd
CY2024Q2	us-gaap	Assets Assets	1578960	usd
CY2023Q4	us-gaap	Assets Assets	1503626	usd
CY2024Q2	ivdn	Credit Cards Current CreditCardsCurrent	72317	usd
CY2023Q4	ivdn	Credit Cards Current CreditCardsCurrent	71659	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	60646	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	144967	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	98847	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	121938	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	231810	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	338564	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	42362	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	56429	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	42362	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	56429	usd
CY2024Q2	us-gaap	Liabilities Liabilities	274172	usd
CY2023Q4	us-gaap	Liabilities Liabilities	394993	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37839003	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37839003	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36532560	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36532560	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	3784	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3653	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11979124	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11741935	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10636955	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10335578	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-41165	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-301377	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1304788	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1108633	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1578960	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1503626	usd
	us-gaap	Revenues Revenues	366217	usd
	us-gaap	Revenues Revenues	98896	usd
CY2024Q2	us-gaap	Revenues Revenues	300331	usd
CY2023Q2	us-gaap	Revenues Revenues	27249	usd
	us-gaap	Cost Of Revenue CostOfRevenue	186384	usd
	us-gaap	Cost Of Revenue CostOfRevenue	30359	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	151560	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	13349	usd
	us-gaap	Gross Profit GrossProfit	179833	usd
	us-gaap	Gross Profit GrossProfit	68537	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	148771	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	13900	usd
	us-gaap	Operating Expenses OperatingExpenses	206722	usd
	us-gaap	Operating Expenses OperatingExpenses	234974	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	121040	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	121091	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26889	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-166437	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	27731	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-107191	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	7519	usd
CY2024Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
CY2023Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
	us-gaap	Depreciation Depreciation	2329	usd
	us-gaap	Depreciation Depreciation	1537	usd
CY2024Q2	us-gaap	Depreciation Depreciation	1165	usd
CY2023Q2	us-gaap	Depreciation Depreciation	768	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	11946	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	11231	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4338	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4632	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14275	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5249	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5503	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5400	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41164	usd
	us-gaap	Net Income Loss NetIncomeLoss	-171686	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	22228	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-112591	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.001
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.005
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.003
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37834682	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37459401	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35177560	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.001
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.005
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.001
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.003
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37834682	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37461096	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35908060	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1003072	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	110000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5940	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-59094	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1059918	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-112591	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	947327	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1108633	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	105920	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	121400	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-63393	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1272560	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	22228	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1304788	usd
	us-gaap	Profit Loss ProfitLoss	-41165	usd
	us-gaap	Profit Loss ProfitLoss	-171686	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2329	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1537	usd
	ivdn	Increase Decrease In Credit Cards IncreaseDecreaseInCreditCards	658	usd
	ivdn	Increase Decrease In Credit Cards IncreaseDecreaseInCreditCards	0	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-107412	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	68125	usd
	ivdn	Increase Decrease In Interest And Other Receivables IncreaseDecreaseInInterestAndOtherReceivables	92120	usd
	ivdn	Increase Decrease In Interest And Other Receivables IncreaseDecreaseInInterestAndOtherReceivables	-9294	usd
	ivdn	Increase Decrease In Inventory IncreaseDecreaseInInventory	-25834	usd
	ivdn	Increase Decrease In Inventory IncreaseDecreaseInInventory	133775	usd
	ivdn	Decrease In Prepaid Expenses DecreaseInPrepaidExpenses	-8342	usd
	ivdn	Decrease In Prepaid Expenses DecreaseInPrepaidExpenses	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-220218	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-226505	usd
	ivdn	Deposits On Machinery Equipment DepositsOnMachineryEquipment	-0	usd
	ivdn	Deposits On Machinery Equipment DepositsOnMachineryEquipment	-19834	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	19834	usd
	ivdn	Proceeds From Issuance Of Additional Paid In Capital ProceedsFromIssuanceOfAdditionalPaidInCapital	237320	usd
	ivdn	Proceeds From Issuance Of Additional Paid In Capital ProceedsFromIssuanceOfAdditionalPaidInCapital	115940	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	14067	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	107555	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	223253	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8385	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3035	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-198286	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	238677	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	263293	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241712	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65007	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_807_eus-gaap--BasisOfAccounting_zMdbzFoNVmP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">1.</td><td><span id="xdx_82B_zMsadsDLNNOa">BASIS OF PRESENTATION</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">In the opinion of management, the accompanying unaudited financial statements contain all adjustments necessary to present fairly Innovative Designs, Inc.’s (the “Company”) financial position as of April 30, 2024, the changes therein for the six-month periods that ended and the results of operations for the six-month periods ended April 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The condensed financial statements included in the Form 10-Q (the “Form”) are presented in accordance with the requirements of the Form and do not include all of the disclosures required by generally accepted accounting principles in the United States of America. For additional information, reference is made to the Company’s annual report on Form 10-K for the fiscal year ending October 31, 2023. The results of operations for the six-month period ending April 30, 2024 are not necessarily indicative of operating results for the full year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s unaudited consolidated financial statements have been prepared in accordance with GAAP and pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this report, as is permitted by such rules and regulations. Accordingly, these consolidated financial statements should be read in conjunction with the audited financial statements as of and for the year ended October 31, 2023, and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended October 31, 2023, filed with the SEC on ???? the “2023 Annual Report”). The results for any interim period are not necessarily indicative of results for any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited consolidated financial statements have been prepared on the same basis as the audited financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all adjustments that are necessary to present fairly the Company’s financial position and results of operations for the interim periods presented. The results for the three and six months ended April 30, 2024, are not necessarily indicative of the results for the year ending October 31, 2024 , or for any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of April 30, 2024, there have been no material changes in the Company’s significant accounting policies from those that were disclosed in the 2023 Annual Report. </span></p>
	us-gaap	Profit Loss ProfitLoss	-41165	usd
CY2024Q2	ivdn	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	-10678120	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	332	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31050	usd
CY2024Q2	ivdn	Accounts Receivable Current AccountsReceivableCurrent	124450	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	65600	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	65600	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	589043	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.060	pure
CY2023Q4	us-gaap	Secured Debt SecuredDebt	100000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.20
CY2024Q1	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	47244	usd
CY2023Q1	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	147450	usd
CY2024Q1	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2023Q1	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.12	pure
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2429443	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2373888	shares
CY2024Q2	ivdn	Shipping And Handling Costs ShippingAndHandlingCosts	19461	usd
CY2023Q4	ivdn	Shipping And Handling Costs ShippingAndHandlingCosts	19444	usd
CY2024Q2	ivdn	Deposits On Equipments DepositsOnEquipments	652944	usd
CY2023Q4	ivdn	Deposits On Equipments DepositsOnEquipments	652944	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
	ivdn	Lease Rou Description LeaseROUDescription	The Company entered into a lease for office space at the time the Company was formed through June 2022.
CY2022Q2	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	260000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-001521-index-headers.html	Edgar Link	pending
0001731122-24-001521-index.html	Edgar Link	pending
0001731122-24-001521.txt	Edgar Link	pending
0001731122-24-001521-xbrl.zip	Edgar Link	pending
e5922_10q.htm	Edgar Link	pending
e5922_ex31-1.htm	Edgar Link	pending
e5922_ex31-2.htm	Edgar Link	pending
e5922_ex32-1.htm	Edgar Link	pending
e5922_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ivdn-20240430.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
e5922_10q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ivdn-20240430_lab.xml	Edgar Link	unprocessable
ivdn-20240430_cal.xml	Edgar Link	unprocessable
ivdn-20240430_pre.xml	Edgar Link	unprocessable
ivdn-20240430_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVDN
INNOVATIVE DESIGNS INC Stock $ivdn

2024 Q3 Form 10-Q Financial Statement

#000173112224001521 Filed on October 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVDN INNOVATIVE DESIGNS INC Stock $ivdn

2024 Q3 Form 10-Q Financial Statement

#000173112224001521 Filed on October 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVDN
INNOVATIVE DESIGNS INC Stock $ivdn